Company profile: Salubris
1.1 - Company Overview
Company description
- Provider of comprehensive pharmaceutical solutions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Salubris
Genkyotex
HQ: Switzerland
Website
- Description: Provider of innovative drugs and platform technology that block NOX enzymes producing oxygen radicals to treat oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy. Offerings include setanaxib and a NOX inhibitor platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genkyotex company profile →
Oxford Pharmascience
HQ: United Kingdom
Website
- Description: Provider of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take, licensing its technologies and dossiers to a network of partners rather than manufacturing or selling directly to consumers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Pharmascience company profile →
Anji Pharma
HQ: United States
Website
- Description: Provider of therapeutics targeting high-value, human genetics-validated targets, including ANJ900, a gut-targeted formulation of metformin for type 2 diabetes patients with advanced chronic kidney disease to lower glucose with reduced systemic exposure, and ANJ908 (Pradigastat), a DGAT1 inhibitor for chronic idiopathic constipation to increase bowel movement frequency and soften stool.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anji Pharma company profile →
Pearl Therapeutics
HQ: United States
Website
- Description: Provider of unique dual and triple combination inhaled therapies for widely prevalent respiratory diseases, including chronic obstructive pulmonary disease, delivered via familiar metered dose inhalers to broaden patient access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pearl Therapeutics company profile →
Veru
HQ: United States
Website
- Description: Provider of novel medicines and healthcare products, including enobosarm to prevent muscle loss in patients using GLP-1 drugs and to treat metastatic breast cancer; sabizabulin for hospitalized patients with viral-induced ARDS; and the FDA-approved FC2 Female Condom for prevention of pregnancy and sexually transmitted infections, available by prescription.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veru company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Salubris
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Salubris
2.2 - Growth funds investing in similar companies to Salubris
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Salubris
4.2 - Public trading comparable groups for Salubris
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →